Paion recently unveiled results of a midstage trial that took advantage of a new imaging method, called diffusion-perfusion MRI, to pinpoint patients best suited to receive the drug up to nine hours after a stroke.
Bosniak uses a complicated algorithm of CT scan characteristics such as size, density and perfusion to place cystic renal masses into one of five different categories.